Researchers have discovered new insights about lymphangioleiomyomatosis (LAM), a rare lung disease, which affects about 1 in 200,000 Americans and commonly features the growth of abnormal cells in different tissues and organs, ...
Feb 2, 2022
0
13
Human lungs, like all organs, begin their existence as clumps of undifferentiated stem cells. But in a matter of months, the cells get organized. They gather together, branch and bud, some forming airways and others alveoli, ...
May 3, 2017
0
1
A new study looking at the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis, a rare and devastating lung disease, found multiple genetic associations with the disease, including one gene variant that ...
Apr 16, 2013
0
0
(HealthDay)—Articles relating to diffuse parenchymal lung disease, asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary diagnostics, and respiratory infections are included in a special update summary ...
May 9, 2015
0
17
An international team of researchers has revealed how scarring occurs in long COVID and pulmonary fibrosis using innovative blood biomarkers and X-ray technology. This study, published in eBioMedicine, contributes to the ...
Nov 2, 2022
0
5
Radiation-induced pulmonary fibrosis—tissue scarring that can permanently impair lung function—limits the delivery of therapeutic radiation doses to non-small cell lung cancer.
Nov 16, 2017
0
0
Amy Chastain didn't think she would be able to be a mom. She didn't think her child would be born with the same debilitating disease as her.
Dec 13, 2019
0
3
Staphylococcus aureus (which includes MRSA) is the most prevalent organism isolated from the airways of children with cystic fibrosis (CF), and is treated using antibiotics, but its role in lung disease is poorly understood.
Nov 19, 2020
0
0
Treatments for the same opportunistic bacteria found in cystic fibrosis patients can work in one area in the lung and be less effective in others. The reason, reported August 20 in Cell Host & Microbe, is that bacteria become ...
Aug 20, 2015
0
9
Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.
Feb 22, 2016
0
16
